Paris, France · Founded 2022 · Privately Held (backing)
Developer of a bacterial detection technology designed to develop technological tools to help the food and beverage industry. Spore.Bio is based in Paris, France and was founded in 2022. Its last reported valuation was $60.6 million in Feb 2025. It has raised $31.7 million.
Last reported valuation
$60.6M
Oct 2026
Priced at
—
Total raised
$31.7M
Last round
—
Team — not yet on record
No current team members for Spore.Bio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Spore.Bio with a free account
·The complete investor list: 23 names
·Watch Spore.Bio: the Monday email on marks, rounds and moves
